Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110718522 | 11071852 | 2 | F | 201410 | 20160818 | 20150428 | 20160830 | EXP | SE-SA-2015SA052216 | AVENTIS | 77.00 | YR | E | F | Y | 0.00000 | 20160830 | MD | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110718522 | 11071852 | 1 | PS | FLUDARA | FLUDARABINE PHOSPHATE | 1 | Oral | U | UNK | 20038 | 10 | MG | QD | ||||||
| 110718522 | 11071852 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | UNK | 0 | |||||||||
| 110718522 | 11071852 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | U | UNK | 0 | |||||||||
| 110718522 | 11071852 | 4 | C | TAVANIC | LEVOFLOXACIN | 1 | 500MG TABLET | 0 | 500 | MG | TABLET | QD | |||||||
| 110718522 | 11071852 | 5 | C | BETAPRED | BETAMETHASONE SODIUM PHOSPHATE | 1 | 4MG/ML | 0 | SOLUTION FOR INJECTION | ||||||||||
| 110718522 | 11071852 | 6 | C | ALVEDON | ACETAMINOPHEN | 1 | 0 | TABLET | |||||||||||
| 110718522 | 11071852 | 7 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | ONE SACHET DAILY FOR 3 DAYS WITH START THE NEXT DAY (16-OCT-2014) | 0 | 8 | MG | TABLET | ||||||||
| 110718522 | 11071852 | 8 | C | DELTISON | PREDNISONE | 1 | 50MG | 0 | 50 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110718522 | 11071852 | 1 | B-cell small lymphocytic lymphoma |
| 110718522 | 11071852 | 2 | B-cell small lymphocytic lymphoma |
| 110718522 | 11071852 | 3 | B-cell small lymphocytic lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110718522 | 11071852 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110718522 | 11071852 | Abdominal discomfort | |
| 110718522 | 11071852 | Anaemia | |
| 110718522 | 11071852 | Asthenia | |
| 110718522 | 11071852 | C-reactive protein increased | |
| 110718522 | 11071852 | Diarrhoea | |
| 110718522 | 11071852 | Fatigue | |
| 110718522 | 11071852 | General physical health deterioration | |
| 110718522 | 11071852 | Nausea | |
| 110718522 | 11071852 | Pyrexia | |
| 110718522 | 11071852 | Syncope | |
| 110718522 | 11071852 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110718522 | 11071852 | 1 | 20141016 | 20141018 | 0 | |
| 110718522 | 11071852 | 2 | 20141015 | 20141015 | 0 | |
| 110718522 | 11071852 | 3 | 20141016 | 20141018 | 0 |